NetworkNewsBreaks – Lexaria Bioscience Corp.’s
Post# of 721
(Total Views: 371)
Posted On: 07/11/2019 3:37:52 PM
NetworkNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTC: LXRP) DehydraTECH to be Leveraged Through CBD License Agreement with Universal Hemp
Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTC: LXRP) today announced its entry into a definitive five-year agreement, via its subsidiary Lexaria Hemp Corp., to provide its patented DehydraTECH(TM) technology to Universal Hemp LLC. Under the agreement, Universal Hemp, a B2B manufacturer of high-performing hemp-derived bulk ingredients to the consumer packaged goods and nutraceutical industries, will utilize the technology in many CBD-based food ingredients to be produced and sold across the U.S. immediately, as well as in Canada when regulations permit. “We are very excited about signing this licensing agreement with Lexaria Bioscience to bring to market Lexaria’s highly effective delivery system which makes cannabidiol or hemp-derived CBD readily available in the human body,” Universal Hemp CEO and Founder Chad Kahunahana said in the news release. “Lexaria’s unique technology was developed over many years for specified applications and is now, for the first time, being applied to CBD at scale and available for general use. We anticipate our SuperBio Infusion line of ingredients will become the industry leader for CBD-infused health and beauty, food and beverage, wellness, athletic and other products where maximum performance is vital. In terms of bioavailability, shelf stability and taste this is the best performing technology in the market, hands down. Our corporate customers cannot wait to put our water-soluble solution into their products!”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTC: LXRP) today announced its entry into a definitive five-year agreement, via its subsidiary Lexaria Hemp Corp., to provide its patented DehydraTECH(TM) technology to Universal Hemp LLC. Under the agreement, Universal Hemp, a B2B manufacturer of high-performing hemp-derived bulk ingredients to the consumer packaged goods and nutraceutical industries, will utilize the technology in many CBD-based food ingredients to be produced and sold across the U.S. immediately, as well as in Canada when regulations permit. “We are very excited about signing this licensing agreement with Lexaria Bioscience to bring to market Lexaria’s highly effective delivery system which makes cannabidiol or hemp-derived CBD readily available in the human body,” Universal Hemp CEO and Founder Chad Kahunahana said in the news release. “Lexaria’s unique technology was developed over many years for specified applications and is now, for the first time, being applied to CBD at scale and available for general use. We anticipate our SuperBio Infusion line of ingredients will become the industry leader for CBD-infused health and beauty, food and beverage, wellness, athletic and other products where maximum performance is vital. In terms of bioavailability, shelf stability and taste this is the best performing technology in the market, hands down. Our corporate customers cannot wait to put our water-soluble solution into their products!”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)